References
- Lock, E.A., Mitchell, A.M., Elcombe, C.R. Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annu. Rev. Pharmacol. Toxicol. 1989, 29, 145–164.
- Giguere, V. Orphan nuclear receptors: from gene to function. Endocrinol. Rev. 1999, 20, 689–725.
- Issemann, I., Green, S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990, 347, 645–650.
- Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., Wahli, W. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell. 1992, 68, 879–887.
- Werman, A., Hollenberg, A., Solanes, G., Bjorbaek, C., Vidal-Puig, A. J., Flier, J.S. Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin. J. Biol. Chem. 1997, 272, 20230–20235.
- Steinmetz, A.C., Renaud, J. P., Moras, D. Binding of ligands and activation of transcription by nuclear receptors. Annu. Rev. Biophys. Biomol. Struct. 2001, 30, 329–359.
- Cho, M.C., Lee, K., Paik, S.G., Yoon, D.Y. Peroxisome proliferators-activated receptor (PPAR) modulators and metabolic disorders. PPAR Res. 2008, 2008, 679137.
- Reddy, J.K., Hashimoto, T. Peroxisomal beta-oxidation and peroxisome proliferators-activated receptor alpha: An adaptive metabolic system. Annu. Rev. Nutr. 2001, 21, 193–230.
- Chou, C.J., Haluzik, M., Gregory, C., Dietz, K.R., Vinson, C., Gavrilova, O., Reitman, M.L. Wy14,643, a peroxisome proliferators-activated receptor alpha (PPARalpha) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice. J. Biol. Chem. 2002, 277, 24484–24489.
- Vu-Dac, N., Chopin-Delnnoy, S., Gervois, P., Bonnelye, E., Martin, G., Fruchart, J.C., Laudet, V., Staels, B. The nuclear receptors peroxisome proliferators-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-1 expression by fibrates. J. Biol. Chem. 1998, 273, 25713–25720.
- Knight, B.L., Patel, D.D., Humphreys, S.M., Wiggins, D., Gibbons, G.F. Inhibition of cholesterol absorption associated with a PPAR alpha-dependent increase in ABC binding cassette transporter A1 in mice. J. Lipid. Res. 2003, 44, 2049–2058.
- Zandbergen, F., Plutzky, J. PPARalpha in Atherosclerosis and inflammation. Biochem. Biophys Acta. 2007, 1771, 972–982.
- Chinetti, G., Gbaguidi, F.G., Griglio, S., Mallat, Z., Antonucci, M., Poulain, P., Chapman, J., Fruchart, J.C., Tedgui, A., Najib-Fruchart, J., Staels, B. CLA-1/SR-B1 is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferators-activated receptors. Circulation 2000, 101, 2411–2417.
- Dowell, P., Ishmael, J.E., Avram, D., Peterson, V.J., Nevrivy, D.J., Leid, M. p300 functions as a coavtivator for the peroxisome proliferators-activated receptor alpha. J. Biol. Chem. 1997, 272, 33435–33443.
- Miao, B., Sun, S., Santomenna, L.D., Zhang, J.H., Young, P., Mukherjee, R. Ligand-induced coactivator recruitment to peroxisome proliferators-activated receptor alpha characterized by fluorescence resonance energy transfer. Methods Enzymol. 2002, 357, 180–188.
- Cho, M.C., Yoon, H.E., Kang, J.W., Park, S.W., Yang, Y., Hong, J.T., Song, E.Y., Paik, S.G., Kim, S.H., Yoon, D.Y. A simple method to screen ligands of peroxisome proliferators-activated receptor delta. Eur. J. Pharm. Sci. 2006, 29, 355–360.
- Mckenna, N.J., Lanz, R.B, O’ Malley B.W. Nuclear receptor coactivators: Cellular and molecular biology. Endocr. Rev. 1999, 20, 321–344.
- Lim, H.J., Moon, I., Han, K. Transcription cofactor exhibit differential preference toward peroxisome proliferators-activated receptors alpha and delta in uterine cells. Endocrinology. 2004, 145, 2886–2895.
- Corton, J.C., Anderson, S.P., Stauber, A. Central role of perosixome proliferators-activated receptors in the actions of peroxisome proliferators. Annu. Rev. Pharmacol. Toxicol. 2000, 40, 491–518.
- Fruchart, J.C. Novel peroxisome proliferators activated receptor-alpha agonist. Am. J. Cardiol. 2007, 100, n41–46.
- Lee, H.S., Cho, M.C., Baek, T.W., Choe, Y.K., Kim, J.W., Hong, J.T., Myung, P.K., Paik, S.G., Yoon, D.Y. Epitope analysis of PPARgamma monoclonal antibody Pgamma48.34A and its application for screening PPARgamma ligands. J. Immunol. Methods. 2005, 296, 125–134.